DKSH has acquired two ear care brands, Audisol and Audiplugs, from Noru Pharma to expand its Healthcare Own Brands business in Australia, New Zealand, and selected Asian markets.

Information on the Target

DKSH has finalized an agreement to acquire two ear care brands, Audisol and Audiplugs, from Noru Pharma. This acquisition specifically targets markets in Australia, New Zealand, and select regions in Asia. Audisol offers a diverse range of products geared towards everyday ear treatment needs, while Audiplugs provides a comprehensive selection of high-quality earplugs. Currently, these brands are available in Australia, New Zealand, and Singapore, with plans for DKSH to introduce them to additional markets in the future.

Industry Overview in Australia and New Zealand

The healthcare market, particularly the over-the-counter (OTC) pharmacy sector, is experiencing significant growth in Australia and New Zealand, driven by increasing consumer awareness regarding personal health and wellness. With a rising trend towards self-medication, consumers are opting for accessible healthcare options, enhancing the demand for ear care products. Notably, this segment has seen a surge in demand, underpinned by aging populations, which are increasingly susceptible to ear-related issues.

In recent years, Australia and New Zealand have witnessed a consistent rise in the healthcare industry, characterized by advancements in pharmaceuticals and a greater emphasis on preventative care. The combination of technological